The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I was the exact same in Halifax. 15k ready to top up - no joy.
Do I recall correctly that there were circa $15 each at 70% GM?
There will be very minimal current demand for antibody lab tests - all antigen. Being the main player in town for antibody with MHRA approval and the Mologic antigen will be what we need. Breaking free of the government will be the catalyst. Ncyt went off to the races well before the government took any notice
Our main problem is that we are selling to the government. The critical approval is MHRA - then we are in a new world
Sorry min of 10 times
What a lot of people will think it that making profit is only selling. In a manufacturing business this is also a balance of uptime on costs. Where odx will have been on historic numbers is generally struggling to absorb costs. They are taking manufacturing volume up by a min of times from the same manufacturing footprint. Yes ship and bill profits will flow but they will be absorbing costs during high volume production which is now and for a foreseeable period. This may well result in significant transfer of gross margin profits to EBITDA as profits pass break even thresholds and incremental returns are earned
He sort of answered that question. If the government is to buy then they would go for it as he explained for the antibody test. Note the capacity charts took the quantity manufactured to be greater than the ODX share of the 1 m rtc tests. I’d hope that the home test approval has a backstop of the orders shipping.... eventually. As a side I was speaking to a lab who are trying to pick up nhs testing contracts sand they can only say that the timeline is just so extended it’s unreal so it’s not just Colin who is experiencing it. My feel was that he is the sort of guy that gets a niche in the market and just burrows and burrows. Given their position I don’t think anyone will be able to touch them in 6 months time. Good presentation - could do with a better CFO.
Vanilla trading update in a period we knew there wouldn’t be covid sales. This could have been buouyed by some order book information or the level of talks ongoing. I do think this is all a little much for the ODX team who are not used to the limelight. Very scientific which will drive the underlying value but cannot expect them to be that gifted all rounders.
This is only the beginning of the anti-body test. You have to be patient and know it will come through in the financials of the company. Whilst others terminate positions and close. ODX hire and take in orders. The global market is massive and as part of the rtc plus government orders under their belt the mountain will come to Mohammed.
I did think they maybe opted for after hours presentation as a result of the share price volatility in the last event .
Disgusting this happens in our country. Just disgusting and enraging
100% correct. I for one am not looking forward to another presentation from Colin - not his strength
So wi it be cold stacked or warm stacked. Can they afford to get it to market in the spring in working condition. Obviously the plan has not worked out and it is not known whether this will be a good or bad move. What is given is that the risk profile on an already risky poorly performing company has just increased. Back to sleep for the winter
I am a bit disappointed that the capacity has not increased to a higher level but at the moment it is not yet required and I expect it is being managed from a syndicate position. Reading the rns a few times it is a very humble statement. Government has first refusal. Government has right to permit or reject sales to third parties. Feels to have strong undertones of a gentlemen’s agreement or one strongly underpinned by a healthcare ethics. I get the impression they are playing for a goal that we do not yet know or is not yet clear. Share price reaction today was poor but if this was a bad rns it would have dropped more. The announcement does not play into the aim sweet spot. Not ramping in any way. If they had rolled out and made a big deal about a government first refusal (not exclusivity - commercially well played) then maybe the herd would be running here. Hopefully home test capability rolls out soon. I can see a large retailer looking to place a big order and we will have to see where the government is at that point. Note high street retailers are ripping up the rule book and targeting what they think will make the money in this market.
Poor manufacturing ramp up but the wise man never made only one thing on his factory. Real demand will be growing into the end of the year
I believe the most important trait with a covid stock is the ability to look forward and be patient today. GLA
Believe he is referring to the Mologic swan test that was run at Heathrow which should be cleared by Christmas. Whether it will or not or is be another thing. No point arguing until it happens
I don’t know if we are in truth. I am long on this but the main thing that odx needs to do is make sales fast in the climate. We need a flow now or we will be the company with a great test but no sales. The global market is key here and I just hope we are not tied by the government in both wider sales and use at home status. As everyone on this board would agree, if available in the shops you’d have bought a few by now for you and the family. Everyone would do the same, none available for the government if that occurs. You zoom out, uk rtc, government order - although only a stocking filler - this has to be positive. I still think we need a faster flurry of sales results, all imo gla
Who are the many people? And how do I join them?
No bo - bp